McClain KM, Prabhu VS, Marupuru S, Meng K, et al. Real-world outcomes of first-line pembrolizumab monotherapy among dMMR/MSI-H
advanced or recurrent endometrial cancer patients in the United States. Gynecol Oncol 2026 Oct 9:S0090-8258(26)02101.
PMID: 42855328
|